Nanostructured polyelectrolyte complexes based on chitosan and sodium alginate containing rifampicin for the potential treatment of tuberculosis

Detalhes bibliográficos
Autor(a) principal: Turco, Bruna Ortolani [UNESP]
Data de Publicação: 2021
Outros Autores: Boni, Fernanda Isadora [UNESP], Gremião, Maria Palmira Daflon [UNESP], Chorilli, Marlus [UNESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1080/03639045.2022.2048664
http://hdl.handle.net/11449/241087
Resumo: Nanostructured polyelectrolyte complexes (nano PECs) were obtained by polyelectrolyte complexation technique from chitosan (CS) and sodium alginate (SA). Different polymer proportions were tested, as well as the addition order and homogenization type, to assess the influence on the nano PECs characteristics. The spherical shape and nanometric scale of the systems were observed by scanning electron microscopy (SEM). Nano PECs size, PDI, and zeta potential (ZP) ranged from 252 to 616 nm, from 0.22 to 0.73 and −50 to 30 mV, respectively. The increase of polymer proportion and the ultra-turrax homogenization led to the enlargement of particles size and PDI. However, no influence was observed on the ZP. The NP1s-Rb and NP4s-Rb, obtained through the sonicator with rifampicin (RIF) added before the CS and SA complexation, were selected due to the most promising characteristics of diameter (301 and 402 nm), PDI (0.27 and 0.26), and RIF incorporation (78 and 69%). The release profiles of RIF incorporated in both nano PECs were similar, with a sustained release of the drug for 180 min in phosphate buffer pH 7.2. The Weibull and the Korsmeyer–Peppas models better describe the RIF release from NP1s-Rb and NP4s-Rb, respectively, demonstrating that the release process was driven by different mechanism according to the particle composition. The nano PECs were lyophilized to prolong it stability and for possible nebulization. The addition of dextrose to the system allowed for resuspension after lyophilization. Therefore, with the results obtained, the incorporation of RIF in nano PECs based on CS and SA presents a promising system for the treatment of tuberculosis.
id UNSP_51828b55b5db85258b6a22f98ac3fd7d
oai_identifier_str oai:repositorio.unesp.br:11449/241087
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Nanostructured polyelectrolyte complexes based on chitosan and sodium alginate containing rifampicin for the potential treatment of tuberculosismanufacturing parametersMycobacterium tuberculosispolyelectrolyte complexesrifampicinTuberculosisNanostructured polyelectrolyte complexes (nano PECs) were obtained by polyelectrolyte complexation technique from chitosan (CS) and sodium alginate (SA). Different polymer proportions were tested, as well as the addition order and homogenization type, to assess the influence on the nano PECs characteristics. The spherical shape and nanometric scale of the systems were observed by scanning electron microscopy (SEM). Nano PECs size, PDI, and zeta potential (ZP) ranged from 252 to 616 nm, from 0.22 to 0.73 and −50 to 30 mV, respectively. The increase of polymer proportion and the ultra-turrax homogenization led to the enlargement of particles size and PDI. However, no influence was observed on the ZP. The NP1s-Rb and NP4s-Rb, obtained through the sonicator with rifampicin (RIF) added before the CS and SA complexation, were selected due to the most promising characteristics of diameter (301 and 402 nm), PDI (0.27 and 0.26), and RIF incorporation (78 and 69%). The release profiles of RIF incorporated in both nano PECs were similar, with a sustained release of the drug for 180 min in phosphate buffer pH 7.2. The Weibull and the Korsmeyer–Peppas models better describe the RIF release from NP1s-Rb and NP4s-Rb, respectively, demonstrating that the release process was driven by different mechanism according to the particle composition. The nano PECs were lyophilized to prolong it stability and for possible nebulization. The addition of dextrose to the system allowed for resuspension after lyophilization. Therefore, with the results obtained, the incorporation of RIF in nano PECs based on CS and SA presents a promising system for the treatment of tuberculosis.Department of Drugs and Medicines Faculdade de Ciências Farmacêuticas UNESP–Univ. Estadual PaulistaDepartment of Drugs and Medicines Faculdade de Ciências Farmacêuticas UNESP–Univ. Estadual PaulistaUniversidade Estadual Paulista (UNESP)Turco, Bruna Ortolani [UNESP]Boni, Fernanda Isadora [UNESP]Gremião, Maria Palmira Daflon [UNESP]Chorilli, Marlus [UNESP]2023-03-01T20:46:29Z2023-03-01T20:46:29Z2021-01-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article1904-1914http://dx.doi.org/10.1080/03639045.2022.2048664Drug Development and Industrial Pharmacy, v. 47, n. 12, p. 1904-1914, 2021.1520-57620363-9045http://hdl.handle.net/11449/24108710.1080/03639045.2022.20486642-s2.0-85131162569Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengDrug Development and Industrial Pharmacyinfo:eu-repo/semantics/openAccess2023-03-01T20:46:29Zoai:repositorio.unesp.br:11449/241087Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462023-03-01T20:46:29Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Nanostructured polyelectrolyte complexes based on chitosan and sodium alginate containing rifampicin for the potential treatment of tuberculosis
title Nanostructured polyelectrolyte complexes based on chitosan and sodium alginate containing rifampicin for the potential treatment of tuberculosis
spellingShingle Nanostructured polyelectrolyte complexes based on chitosan and sodium alginate containing rifampicin for the potential treatment of tuberculosis
Turco, Bruna Ortolani [UNESP]
manufacturing parameters
Mycobacterium tuberculosis
polyelectrolyte complexes
rifampicin
Tuberculosis
title_short Nanostructured polyelectrolyte complexes based on chitosan and sodium alginate containing rifampicin for the potential treatment of tuberculosis
title_full Nanostructured polyelectrolyte complexes based on chitosan and sodium alginate containing rifampicin for the potential treatment of tuberculosis
title_fullStr Nanostructured polyelectrolyte complexes based on chitosan and sodium alginate containing rifampicin for the potential treatment of tuberculosis
title_full_unstemmed Nanostructured polyelectrolyte complexes based on chitosan and sodium alginate containing rifampicin for the potential treatment of tuberculosis
title_sort Nanostructured polyelectrolyte complexes based on chitosan and sodium alginate containing rifampicin for the potential treatment of tuberculosis
author Turco, Bruna Ortolani [UNESP]
author_facet Turco, Bruna Ortolani [UNESP]
Boni, Fernanda Isadora [UNESP]
Gremião, Maria Palmira Daflon [UNESP]
Chorilli, Marlus [UNESP]
author_role author
author2 Boni, Fernanda Isadora [UNESP]
Gremião, Maria Palmira Daflon [UNESP]
Chorilli, Marlus [UNESP]
author2_role author
author
author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (UNESP)
dc.contributor.author.fl_str_mv Turco, Bruna Ortolani [UNESP]
Boni, Fernanda Isadora [UNESP]
Gremião, Maria Palmira Daflon [UNESP]
Chorilli, Marlus [UNESP]
dc.subject.por.fl_str_mv manufacturing parameters
Mycobacterium tuberculosis
polyelectrolyte complexes
rifampicin
Tuberculosis
topic manufacturing parameters
Mycobacterium tuberculosis
polyelectrolyte complexes
rifampicin
Tuberculosis
description Nanostructured polyelectrolyte complexes (nano PECs) were obtained by polyelectrolyte complexation technique from chitosan (CS) and sodium alginate (SA). Different polymer proportions were tested, as well as the addition order and homogenization type, to assess the influence on the nano PECs characteristics. The spherical shape and nanometric scale of the systems were observed by scanning electron microscopy (SEM). Nano PECs size, PDI, and zeta potential (ZP) ranged from 252 to 616 nm, from 0.22 to 0.73 and −50 to 30 mV, respectively. The increase of polymer proportion and the ultra-turrax homogenization led to the enlargement of particles size and PDI. However, no influence was observed on the ZP. The NP1s-Rb and NP4s-Rb, obtained through the sonicator with rifampicin (RIF) added before the CS and SA complexation, were selected due to the most promising characteristics of diameter (301 and 402 nm), PDI (0.27 and 0.26), and RIF incorporation (78 and 69%). The release profiles of RIF incorporated in both nano PECs were similar, with a sustained release of the drug for 180 min in phosphate buffer pH 7.2. The Weibull and the Korsmeyer–Peppas models better describe the RIF release from NP1s-Rb and NP4s-Rb, respectively, demonstrating that the release process was driven by different mechanism according to the particle composition. The nano PECs were lyophilized to prolong it stability and for possible nebulization. The addition of dextrose to the system allowed for resuspension after lyophilization. Therefore, with the results obtained, the incorporation of RIF in nano PECs based on CS and SA presents a promising system for the treatment of tuberculosis.
publishDate 2021
dc.date.none.fl_str_mv 2021-01-01
2023-03-01T20:46:29Z
2023-03-01T20:46:29Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1080/03639045.2022.2048664
Drug Development and Industrial Pharmacy, v. 47, n. 12, p. 1904-1914, 2021.
1520-5762
0363-9045
http://hdl.handle.net/11449/241087
10.1080/03639045.2022.2048664
2-s2.0-85131162569
url http://dx.doi.org/10.1080/03639045.2022.2048664
http://hdl.handle.net/11449/241087
identifier_str_mv Drug Development and Industrial Pharmacy, v. 47, n. 12, p. 1904-1914, 2021.
1520-5762
0363-9045
10.1080/03639045.2022.2048664
2-s2.0-85131162569
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Drug Development and Industrial Pharmacy
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 1904-1914
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1799965534737924096